SPP1629 coordination project

这个DFG优先计划关注的问题是：什么定义了健康和疾病的甲状腺功能？为了回答这一问题，TRANSPAN ACT建立了一个网络和协调结构，整合了德国领先的甲状腺研究实验室和中心的努力。SPP1629旨在将基础科学的发现转化为长期更好的患者治疗选择。特别是，我们成功地招募了积极进取、有能力的初级科学家，他们进入了这个新兴的研究领域。该联盟还通过促进有经验的德国科学家从国外回国，为内分泌学领域的人才增长做出了贡献。TRANSE TRANS ACT为连接初级科学家提供了一个平台，他们在资深研究人员的指导下积极合作。这些努力得到了重点会议的支持，如SPP1629年会、Arbeitstagung实验学校和Bregenz内分泌学暑期学校。这位年轻科学家的个人职业发展得到了一个教育项目的支持，该项目包括研讨会、实验室交流和确保从不同角度进行监督和反馈的双重指导组成部分。第一个资助期内的许多联合出版物证明，甲状腺TRANS ACT具有高度的协作性。每年举行定期会议，讨论进展情况，并将新的项目想法付诸实施，例如，在开放的氛围中确定标准作业程序、交换材料和分享专业知识。SPP1629的结果还在德国内分泌学学会、欧洲甲状腺协会等会议上以海报或口头演示的形式公布。2014年12月，世界领先的甲状腺病学家出席了TRANSANS ACT的第一次国际会议，对此感到荣幸。在SPP1629内部的交流是通过我们的网站实现的，该网站提供关于甲状腺研究的项目、成员、新闻和热点话题的信息。重要的是，该网站通过其出版物向科学家和感兴趣的普通公众通报SPP1629的结果，而内部区域允许成员共享和交换信息。在下一个资助期，我们将在这些重要成就的基础上再接再厉，目标是支持青年科学家成为独立研究人员。此外，我们将继续支持返回德国的甲状腺研究人员的流动性。我们将推动形成长效的甲状腺TRACT研究网络。特别是，我们的目标是培育新的财团，如研究小组或SFB，这些财团将在德国和国际上充当联系良好的甲状腺研究中心。现在，SPP1629已经帮助加强了德国甲状腺学在国际上的地位。我们将通过将甲状腺反式ACT与其他国际研究联盟联系起来，进一步实现这一目标。

This DFG priority program focuses on the question: WHAT DEFINES HEALTHY AND DISEASED THYROID FUNCTION? To answer this, THYROID TRANS ACT has established a network and coordination structure that integrates the efforts of leading thyroid research laboratories and centers in Germany. SPP1629 aims at translating findings in basic sciences to better treatment options for patients in the long run. In particular, we were successful in recruiting highly motivated and capable junior scientists who entered this emerging field of research. The consortium has also contributed to brain-gain in the field of endocrinology by facilitating the return of experienced German scientists from abroad. THYROID TRANS ACT provides a platform for connecting junior scientists, who are actively collaborating while being guided by senior researchers. These efforts are supported by focus meetings like the Annual Meeting of SPP1629, Arbeitstagung Experimentelle Schilddrüsenforschung and the Bregenz Summer School of Endocrinology. Individual career building is supported by an educational program for the young scientist that involves workshops, lab exchanges and a dual mentorship component ensuring supervision and feedback from different angles. THYROID TRANS ACT is highly collaborative as evidenced by numerous joint publications within the first funding period. Regular meetings take place every year, where progress is discussed and new project ideas are set into action by, e.g., defining SOPs, exchanging material, and sharing expertise in an open atmosphere. The results of SPP1629 are also presented as posters or oral presentations during meetings of the German Society of Endocrinology, the European Thyroid Association, and many more. THYROID TRANS ACT was honored by the attendance of the world-leading thyroidologists at its first International Conference in December 2014. Communication within the SPP1629 is achieved by our website (www.thyroidtransact.de) that provides information on the projects, members, news, and hot topics in thyroid research. Importantly, the website informs both, scientist and the interested lay-public about the results of the SPP1629 through its publications, while an internal area allows the members to share and exchange information. In the next funding period we will build on these important achievements and aim to support young scientists to establish themselves as independent researchers. In addition, we will continue to support mobility of returning thyroid researchers to Germany. We will promote formation of a long-lasting research network emerging from THYROID TRANS ACT. In particular, we aim to seed new consortia such as research groups or SFB that will act as well-connected hubs of thyroid research in Germany and internationally. Already now, the SPP1629 helped to internationally strengthen the position of German thyroidology. We will further pursue this goal by linking THYROID TRANS ACT to other international research consortia.